HUT63848A - Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients - Google Patents

Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients Download PDF

Info

Publication number
HUT63848A
HUT63848A HU922540A HU254092A HUT63848A HU T63848 A HUT63848 A HU T63848A HU 922540 A HU922540 A HU 922540A HU 254092 A HU254092 A HU 254092A HU T63848 A HUT63848 A HU T63848A
Authority
HU
Hungary
Prior art keywords
formula
hydrogen
pyrazol
compounds
trifluoromethyl
Prior art date
Application number
HU922540A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9202540D0 (en
Inventor
Roger Bernard Titman
Michael Henry Hockley
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of HU9202540D0 publication Critical patent/HU9202540D0/hu
Publication of HUT63848A publication Critical patent/HUT63848A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HU922540A 1990-02-06 1991-01-26 Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients HUT63848A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909002423A GB9002423D0 (en) 1990-02-06 1990-02-06 Therapeutic agents

Publications (2)

Publication Number Publication Date
HU9202540D0 HU9202540D0 (en) 1992-10-28
HUT63848A true HUT63848A (en) 1993-10-28

Family

ID=10670368

Family Applications (1)

Application Number Title Priority Date Filing Date
HU922540A HUT63848A (en) 1990-02-06 1991-01-26 Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients

Country Status (16)

Country Link
JP (1) JPH05504141A (enrdf_load_stackoverflow)
KR (1) KR927003600A (enrdf_load_stackoverflow)
AU (1) AU7187791A (enrdf_load_stackoverflow)
BR (1) BR9105990A (enrdf_load_stackoverflow)
CA (1) CA2074816A1 (enrdf_load_stackoverflow)
FI (1) FI923528A0 (enrdf_load_stackoverflow)
GB (1) GB9002423D0 (enrdf_load_stackoverflow)
HU (1) HUT63848A (enrdf_load_stackoverflow)
IE (1) IE910287A1 (enrdf_load_stackoverflow)
IL (1) IL97109A0 (enrdf_load_stackoverflow)
IN (1) IN172129B (enrdf_load_stackoverflow)
MX (1) MX24407A (enrdf_load_stackoverflow)
NO (1) NO923082L (enrdf_load_stackoverflow)
PT (1) PT96687A (enrdf_load_stackoverflow)
WO (1) WO1991012255A1 (enrdf_load_stackoverflow)
ZA (1) ZA91833B (enrdf_load_stackoverflow)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9116241D0 (en) * 1991-07-27 1991-09-11 Boots Co Plc Therapeutic agents
NZ540081A (en) 2002-11-22 2008-03-28 Active Biotech Ab Pyrazoloquinolines with immunomodulating activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA895646B (en) * 1988-08-09 1990-04-25 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
CA2074816A1 (en) 1991-08-07
IN172129B (enrdf_load_stackoverflow) 1993-04-10
BR9105990A (pt) 1992-11-10
ZA91833B (en) 1991-10-30
MX24407A (es) 1993-10-01
IL97109A0 (en) 1992-03-29
JPH05504141A (ja) 1993-07-01
HU9202540D0 (en) 1992-10-28
PT96687A (pt) 1991-10-31
GB9002423D0 (en) 1990-04-04
FI923528A7 (fi) 1992-08-05
NO923082D0 (no) 1992-08-05
WO1991012255A1 (en) 1991-08-22
AU7187791A (en) 1991-09-03
IE910287A1 (en) 1991-08-14
NO923082L (no) 1992-08-05
FI923528L (fi) 1992-08-05
FI923528A0 (fi) 1992-08-05
KR927003600A (ko) 1992-12-18

Similar Documents

Publication Publication Date Title
EP1206467B1 (en) N-heterocyclic derivatives as nos inhibitors
TWI449696B (zh) 以5員雜環為主之p38激酶抑制劑
US5436247A (en) Quinoline or quinazoline derivatives, their production and use
CH664152A5 (fr) Derives de tetrahydrocarbazolones.
JPH07324076A (ja) 新規なピラゾール−3−カルボキサミド誘導体、これらを製造するための方法及びこれらが存在する薬学的組成物
EP0417653A1 (en) 3-(1-Substituted-4-piperazinyl)-1H-indazoles, a process for their preparation and their use as medicaments
JP2001512118A (ja) オキシドスクアレン−シクラーゼを阻害するピリジル−およびピリミジル複素環式化合物
EP0116769B1 (en) Dihydropyridines
JP2007523139A (ja) 治療薬
HUT64523A (en) Process for producing 3-substituted-1-(aryl- or aryl-alkyl)-2(1h)-quinolones and medical preparatives containing them
RU1838299C (ru) Способ получени производных пиперидина или их солей с кислотами
EP0266899A2 (en) Indole derivatives
FR2465732A1 (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique
HU196989B (en) Process for producing quinoline derivatives and pharmaceuticals comprising same
EP0107619B1 (en) Dihydropyrazolo(3,4-b)pyridine derivatives and production thereof
EP0314363A2 (en) Anti-anxiety agents
EP1758910A1 (en) Substituted triazole derivatives as oxytocin antagonists
JP5069894B2 (ja) ピラゾール化合物
JP4994295B2 (ja) 医薬組成物
JPH05246980A (ja) β−オキソ−β−ベンゼンプロパンチオアミド誘導体
HUT63848A (en) Process for producing pharmaceutical compositions comprising new 1-benzopyrqno/4,3-c/pyrazole derivatives and their active ingredients
US4395409A (en) Carbamoyloxyamino-1,4-benzodiazepines and medicaments containing these compounds
JPH06199855A (ja) ピラゾロピリジン誘導体及びこれを含有する血小板凝集抑制剤
TW200948798A (en) (5R)-1, 5-diaryl-4, 5-dihydro-1H-pyrazole-3-carboxamidine derivatives having CB1-antagonistic activity
US4985427A (en) Triazine derivatives

Legal Events

Date Code Title Description
DFA9 Temporary protection cancelled due to abandonment
DFC4 Cancellation of temporary protection due to refusal